Mereo BioPharma (MREO) Accumulated Expenses (2022 - 2026)
Mereo BioPharma's Accumulated Expenses came in at $2.46 million for Q2 2026, down 51.3% from $5.04 million a year earlier but up 20.0% from the prior quarter.
Powered by 
Analysis
Mereo BioPharma (MREO) Accumulated Expenses (2022 - 2026) Analysis & Trends
At the end of FY2025, Mereo BioPharma's Accumulated Expenses was $2.03 million, down 50.2% from FY2024.
- Accumulated Expenses carries a three-year compound annual growth rate of -28.0% (FY2022 to FY2025).
- Going back by year, Accumulated Expenses was $4.07 million in FY2024 (-25.5%), $5.47 million in FY2023 (+0.6%) and $5.44 million in FY2022.
- The five-year range for quarterly Accumulated Expenses is $2.03 million (Q4 2025) to $5.47 million (Q4 2023).
- Year-over-year, Accumulated Expenses has declined for three consecutive quarters, with an average decline of 12.8% over the last seven quarters.
- The fastest year-over-year change in Accumulated Expenses over five years came in Q2 2025 (growth of 35.5%), and the weakest in Q2 2026 (a decline of 51.3%).
- Business Quant data shows MREO's Accumulated Expenses at $2.05 million (Q1 2026), $2.03 million (Q4 2025) and $4.12 million (Q3 2025) in the three quarters before Q2 2026.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Eli Lilly | 1,230.11 Bn | 1,198.70 Bn | 19.71 Bn |
| 2 | Johnson & Johnson | 644.39 Bn | 564.25 Bn | 17.30 Bn |
| 3 | AbbVie | 503.52 Bn | 476.68 Bn | 12.70 Bn |
| 4 | Merck | 363.29 Bn | 317.72 Bn | 12.21 Bn |
| 5 | Novartis Ag | 298.23 Bn | 262.62 Bn | 11.24 Bn |
| 6 | Astrazeneca | 267.53 Bn | 241.29 Bn | 12.86 Bn |
| 7 | Amgen | 241.80 Bn | 197.20 Bn | 7.24 Bn |
| 8 | Gilead Sciences | 195.07 Bn | 169.19 Bn | 6.22 Bn |
| 9 | Pfizer | 173.33 Bn | 120.28 Bn | 10.94 Bn |
| 10 | Mereo BioPharma | 46.31 Mn | -103.60 Mn | - |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 2.46 Mn |
| Mar 31, 2026 | 2.05 Mn |
| Dec 31, 2025 | 2.03 Mn |
| Sep 30, 2025 | 4.12 Mn |
| Jun 30, 2025 | 5.04 Mn |
| Mar 31, 2025 | 2.93 Mn |
| Dec 31, 2024 | 4.07 Mn |
| Sep 30, 2024 | 3.53 Mn |
| Jun 30, 2024 | 3.72 Mn |
| Mar 31, 2024 | 2.54 Mn |
| Dec 31, 2023 | 5.47 Mn |
| Dec 31, 2022 | 5.44 Mn |
API Access
Mereo BioPharma Accumulated Expenses API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=accumulated-expenses&ticker=MREO&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "accumulated-expenses", "ticker": "MREO", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=accumulated-expenses&ticker=MREO&period=max&api_key=YOUR_API_KEY");
const data = await res.json();